• Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer

    Friday June 16th 2023

  • SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance

    Wednesday June 7th 2023

  • HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform

    Tuesday June 6th 2023

  • Belgium reclaims second place in European biotech ranking

    Wednesday May 31st 2023

  • P95 BV and Ampersand Capital Partners join forces to establish first in class vaccine CRO

    Wednesday May 3rd 2023

  • VIB and Ghent University develop new mRNA vaccines against bacterial infections

    Wednesday April 26th 2023

  • Flanders export figures 2022: goods exports up 26%, but growth has slowed since Q4

    Tuesday April 25th 2023

  • ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI

    Monday March 27th 2023

  • Your news here?

  • HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform

    Monday March 27th 2023

  • Celyad Oncology announces non-cash impairment

    Wednesday March 15th 2023

  • VIB spin-off Flamingo Therapeutics merges with Dynacure to create leading RNA therapeutics company in oncology

    Thursday March 2nd 2023


Strategic Partners